158 related articles for article (PubMed ID: 2451137)
1. Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection.
Kuwahara H; Sakurada T; Sakurada S; Yonezawa A; Ando R; Kisara K; Osakada F; Munekata E
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):656-60. PubMed ID: 2451137
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat.
Cridland RA; Henry JL
Brain Res; 1986 Aug; 381(1):93-9. PubMed ID: 2428434
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
Mathison R; Solomos D
Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
[TBL] [Abstract][Full Text] [Related]
4. Behavioural effects of tachykinins and related peptides.
Elliott PJ; Iversen SD
Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
[TBL] [Abstract][Full Text] [Related]
5. Tachykinin-like central activity of neuromedin K in mice.
Vaught JL; Post LJ; Jacoby HI; Wright D
Eur J Pharmacol; 1984 Aug; 103(3-4):355-7. PubMed ID: 6208040
[TBL] [Abstract][Full Text] [Related]
6. Chemoreceptor responses to substance P, physalaemin and eledoisin: evidence for neurokinin-1 receptors in the cat carotid body.
Prabhakar NR; Kou YuR ; Runold M
Neurosci Lett; 1990 Dec; 120(2):183-6. PubMed ID: 1705679
[TBL] [Abstract][Full Text] [Related]
7. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
[TBL] [Abstract][Full Text] [Related]
8. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin.
Andrews PV; Helme RD; Thomas KL
Br J Pharmacol; 1989 Aug; 97(4):1232-8. PubMed ID: 2477105
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.
Hua X; Lundberg JM; Theodorsson-Norheim E; Brodin E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):196-201. PubMed ID: 6084817
[TBL] [Abstract][Full Text] [Related]
10. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
11. A selective and extremely potent antagonist of the neurokinin-1 receptor.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
[TBL] [Abstract][Full Text] [Related]
12. Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.
Moochhala SM; Sawynok J
Br J Pharmacol; 1984 Jun; 82(2):381-8. PubMed ID: 6203593
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the responses to the sensory neuropeptides, substance P, neurokinin A, neurokinin B and calcitonin gene-related peptide and to trigeminal nerve stimulation in the iris sphincter muscle of the rabbit.
Muramatsu I; Nakanishi S; Fujiwara M
Jpn J Pharmacol; 1987 May; 44(1):85-92. PubMed ID: 2442444
[TBL] [Abstract][Full Text] [Related]
14. Mapping of brain sites sensitive to the antidipsogenic effect of tachykinins.
Massi M; de Caro G; Perfumi M; Venturi F
Peptides; 1988; 9(2):347-56. PubMed ID: 2453857
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
16. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
Hall ME; Grantham P; Limoli J; Stewart JM
Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
[TBL] [Abstract][Full Text] [Related]
17. Phosphoramidon potentiates mammalian tachykinin-induced biting, licking and scratching behaviour in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K
Pharmacol Biochem Behav; 1990 Dec; 37(4):779-83. PubMed ID: 1709505
[TBL] [Abstract][Full Text] [Related]
18. Action of the newly discovered mammalian tachykinins, substance K and neuromedin K, on gastroduodenal motility of anesthetized dogs.
Kuwahara A; Yanaihara N
Regul Pept; 1987 Apr; 17(4):221-8. PubMed ID: 2438728
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
Post C; Folkers K
Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for multiple tachykinin receptors.
Growcott JW; Jamieson A; Tarpey AV; Topham LD
Eur J Pharmacol; 1982 Dec; 86(1):59-64. PubMed ID: 6186499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
